Protalix BioTherapeutics Reports Third Quarter 2024 Financial and ...

Sep 30, 2024 · Third Quarter 2024 Financial Highlights The Company recorded revenues from selling goods of $17.8 million during the three months ended September 30, 2024 , an …

CouponFollow Extension

$17
OFF

Protalix BioTherapeutics Reports Third Quarter 2024 Financial And ...

1 week from now

Sep 30, 2024 · Third Quarter 2024 Financial Highlights The Company recorded revenues from selling goods of $17.8 million during the three months ended September 30, 2024 , an …

protalix.com

$0
OFF

Protalix BioTherapeutics Reports Third Quarter 2024 Financial And ...

1 week from now

4 days ago · Financial expenses, net was $0.1 million for the three months ended September 30, 2024, compared to financial income, net of $0.2 million for the three months ended September …

morningstar.com

$91
OFF

Protalix BioTherapeutics Reports Third Quarter 2024 Financial And ...

1 week from now

3 days ago · ATCO Ltd. ATCO Ltd. (ATCO or the Company) today announced third quarter 2024 adjusted earnings of $91 million ($0.81 per share), $10 million ($0.10 per share) higher …

lelezard.com

75%
OFF

Earnings Call: Protalix BioTherapeutics Reports Strong Q3 Growth

1 week from now

Protalix's revenue climbed to $17.8 million in Q3 2024, marking a 75% increase from Q3 2023. The company reported a net income of $3.2 million, or $0.04 per share basic, compared to a …

investing.com

$17
OFF

Protalix BioTherapeutics Reports Third Quarter 2024 Financial An

1 week from now

3 days ago · Third Quarter 2024 Financial Highlights The Company recorded revenues from selling goods of $17.8 million during the three months ended September 30, 2024 , an …

gurufocus.com

75%
OFF

Protalix BioTherapeutics Reports Third Quarter 2024 Financial And ...

1 week from now

3 days ago · Protalix BioTherapeutics (PLX) reported Q3 2024 financial results with revenues from goods of $17.8 million, a 75% increase from Q3 2023.The company achieved net income …

stocktitan.net

$0
OFF

Protalix BioTherapeutics Inc (PLX) Quarterly 10-Q Report

1 week from now

4 days ago · Protalix BioTherapeutics, Inc. has submitted its 10-Q filing for the quarterly period ended September 30, 2024. Revenues from license and R&D services decreased to $0.1 …

qz.com

$199
OFF

Artiva Biotherapeutics Reports Third Quarter 2024 Financial

1 week from now

4 days ago · Robust balance sheet with cash, cash equivalents and investments of $199.6 million as of September 30, 2024, is expected to fund operations at least through end of 2026 SAN …

biospace.com